Grid Exponential

Grid Exponential, founded in 2017 and based in Buenos Aires, Argentina, operates as the first science-based company builder in Latin America. The firm addresses the challenges associated with technology transfer and investment in the region, which has historically hindered the development of successful science-driven enterprises. By establishing a new technology transfer process, Grid Exponential aims to create high-impact, global, disruptive, and sustainable companies across various sectors, including environment, energy, materials, food, diagnostics, agriculture, tools, and health. The organization focuses on building a bridge between innovative scientific research and market applications, fostering the growth of companies that have the potential to make significant contributions to society.

Federico Marque

Partner and COO

Matías Peire

General Partner

Past deals in Nanotechnology

Apasomics

Pre Seed Round in 2024
Apasomics is a biotechnology company specializing in bone-targeted drug delivery. It develops apasome-based nanocarriers to deliver bisphosphonates directly to bones, enhancing treatment efficacy for osteoporosis and other skeletal disorders while minimizing side effects. By combining nanotechnology and precision medicine, Apasomics aims to improve therapeutic outcomes and patient quality of life.

Monte Caldera Technologies

Pre Seed Round in 2024
Monte Caldera Technologies is a science-driven company that applies fundamental physics to develop innovative solutions for various industries. It offers a scientific technology platform that accelerates materials discovery through advanced, physics-based molecular modeling. This platform provides real-time molecular insights and optimization capabilities, helping industries such as chemicals, biotech, energy, and semiconductors enhance their research and development processes, improve sustainability, and reduce waste. Additionally, Monte Caldera provides consulting and molecular-level simulation services tailored to diverse industries.

Qnity

Pre Seed Round in 2023
Qnity leverages quantum electrochemical principles to develop tools for drug discovery and other product innovations.

Gisens Biotech

Pre Seed Round in 2023
Gisens Biotech is a biotechnology company specializing in bioelectronics and nanotechnology. The firm is recognized for its innovative approach to problem-solving and leverages advanced technology to meet its goals. A standout product is the Nano-Lab, a portable diagnostic device that measures and monitors various biomarkers from minimal samples of blood, urine, or saliva. This device is particularly adept at detecting renal biomarkers such as urea, creatinine, and potassium from a single drop of blood. By providing real-time tracking of these concentrations, the Nano-Lab enhances health monitoring capabilities, offering a high level of accuracy and convenience that has the potential to transform traditional biomarker measurement and interpretation methods.

Qumir Nano

Pre Seed Round in 2022
Qumir Nano is a pioneering company that develops and supplies eco-friendly nanoparticles for sustainable agriculture. Utilizing a proprietary bio-nanotechnology platform, the company produces these particles through a green synthesis method that employs microorganisms sourced from jungles. Qumir Nano's products offer nutritional and antimicrobial properties, helping farmers enhance crop health while minimizing pesticide pollution.

Nanotransfer

Pre Seed Round in 2021
Nanotransfer specializes in the development of advanced delivery systems utilizing inorganic nanoparticles for gene therapy applications. These systems offer several advantages, including readiness for immediate use by clients, versatility in transporting various types of nucleic acids, and biosafety characteristics, such as non-immunogenicity, allowing for broad patient eligibility and potential re-administration. The delivery systems are designed for high levels of cellular internalization and can be tailored for specificity towards particular cell types, facilitating customized therapies. Furthermore, they possess chemical affinities for the phosphate backbone of nucleic acids, which enhances their ability to integrate genes irrespective of sequence. This approach enables the decoupling of synthesis for the delivery system and the gene of interest, promoting the development of a wider range of therapies aimed at improving health outcomes. Notably, Nanotransfer's non-viral delivery systems can evade endosomal entrapment and resist enzymatic degradation due to their unique composition and surface properties.

Nanogrow Biotech

Pre Seed Round in 2021
Nanogrow Biotech is a manufacturer of nano antibiotics with the goal of developing novel applications in the pharmaceutical industry, particularly for the treatment of skin diseases.

Gisens Biotech

Pre Seed Round in 2020
Gisens Biotech is a biotechnology company specializing in bioelectronics and nanotechnology. The firm is recognized for its innovative approach to problem-solving and leverages advanced technology to meet its goals. A standout product is the Nano-Lab, a portable diagnostic device that measures and monitors various biomarkers from minimal samples of blood, urine, or saliva. This device is particularly adept at detecting renal biomarkers such as urea, creatinine, and potassium from a single drop of blood. By providing real-time tracking of these concentrations, the Nano-Lab enhances health monitoring capabilities, offering a high level of accuracy and convenience that has the potential to transform traditional biomarker measurement and interpretation methods.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.